2014
DOI: 10.1161/circulationaha.113.005376
|View full text |Cite
|
Sign up to set email alerts
|

Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0
2

Year Published

2016
2016
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 23 publications
(27 reference statements)
0
12
0
2
Order By: Relevance
“…Последнюю дозу рива-роксабана обычно назначают за 24-36 ч до ка-тетерного вмешательства [27,[30][31][32]. Сведения о безопасности использования НОАК при абла-ции в данных исследованиях были противоре-чивы, но в целом вероятность развития тромбо-эмболии и риск кровотечения схожи с таковы-ми при непрерывной стратегии приема АВК [33][34][35].…”
Section: дооперационная стратегия антикоагулянтной терапииunclassified
See 1 more Smart Citation
“…Последнюю дозу рива-роксабана обычно назначают за 24-36 ч до ка-тетерного вмешательства [27,[30][31][32]. Сведения о безопасности использования НОАК при абла-ции в данных исследованиях были противоре-чивы, но в целом вероятность развития тромбо-эмболии и риск кровотечения схожи с таковы-ми при непрерывной стратегии приема АВК [33][34][35].…”
Section: дооперационная стратегия антикоагулянтной терапииunclassified
“…Для больных, принимающих терапию дабигатраном или ри-вароксабаном, возможны либо остановка при-ема одной или двух доз до аблации, либо вы-полнение процедуры без отмены препарата (только в случае ривароксабана) [28][29][30][31][32][33][34][35][36]. Чрес-пищеводную ЭхоКГ необходимо выполнять во всех случаях, когда есть сомнения относитель-но правильности приема соответствующих ан-тикоагулянтов за 3 нед до катетерного вмеша-тельства.…”
Section: дооперационная стратегия антикоагулянтной терапииunclassified
“…1 Anticoagulation is usually required during percutaneous catheter ablation procedures, because of the risk of material and lesion-induced cardiac thrombus and embolism. 2,3 This thrombo-embolic risk persists even in patients under oral anticoagulation, thus additional anticoagulation with unfractionated heparin is needed. 4 Because of combined risks of bleeding and thrombo-embolic events, it is furthermore recommended that anticoagulation levels should be closely monitored during ablation procedures: achieving and maintaining activated clotting time (ACT) > 300 seconds with heparin is currently considered mandatory for ablation of atrial fibrillation 5 and also commmonly used for ablation of ventricular arrhythmias.…”
Section: Introductionmentioning
confidence: 99%
“…4 Because of combined risks of bleeding and thrombo-embolic events, it is furthermore recommended that anticoagulation levels should be closely monitored during ablation procedures: achieving and maintaining activated clotting time (ACT) > 300 seconds with heparin is currently considered mandatory for ablation of atrial fibrillation 5 and also commmonly used for ablation of ventricular arrhythmias. 6 Activated clotting time is a widely accepted coagulation monitoring technique 3,4,7 being perfectly adapted to clinical requirements, since results are very quickly available using bedside coagulation monitoring, allowing immediate adjustment of heparin needs. 8 In patients under long-term oral anticoagulation, ablations are optimally conducted without any interruption of anticoagulant drugs.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation